Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Subject Matter Eligibility of AI Medical Treatments

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Artificial intelligence (AI) has quickly become a springboard for breakthroughs in personalized medicine, enhanced medical...

We are Morrison Foerster — a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, and Fortune 100, technology, and life sciences companies. Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger.Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Prior results do not guarantee a similar outcome.

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Artificial intelligence (AI) has quickly become a springboard for breakthroughs in personalized medicine, enhanced medical imaging, and predictive modeling for drug development. And given the role it played in two recent Nobel Prizes—one in chemistry, and the other in physics—AI appears to have an exceedingly bright future as a driver of innovation.Read the <a href="https://lifesciences.mofo.com/topics/sm-eligibility-of-ai-medical-treatments" target="_blank">full blog post</a>.

Subject Matter Eligibility of AI Medical Treatments

Sign Up

Jack Lane is an associate in Morrison Foerster’s Intellectual Property Litigation Group.Jack received his J.D. magna cum laude from the Northwestern Pritzker School of Law. While in law school, he served as managing editor for the Northwestern University Law Review and competed on the Bartlit Center National Trial Team. Jack also served as a judicial extern to Judge Virginia M. Kendall on the Northern District of Illinois. Jack earned his B.A. in chemistry and mathematics from Johns Hopkins University.

Jack Lane

Associate

Ken has more than 25 years of experience in intellectual property and other complex, high-stakes commercial litigation and trials. His cases have involved a broad range of technology industries, including software, semiconductor, Internet, and medical devices.Ken has successfully brought and defended numerous trade secret cases in state and federal court. He was a member of the team that successfully tried a recent high-profile smartphone case leading to a jury verdict of over $900 million.He also represented the University of California in patent litigation against a leading life sciences company over a pioneering patent involving human growth hormone. The resulting $200 million settlement, reached after a six-week jury trial, remains one of the top-ten settlements in any biotechnology patent case in the United States.Ken also represents public companies and their officers and directors in securities class actions, shareholder derivative suits, internal investigations, and SEC proceedings. He frequently litigates disputes arising out of mergers and acquisitions and other strategic transactions. In addition, he represents privately funded and emerging companies in disputes over corporate governance and breaches of fiduciary duty, as well as in disputes among boards of directors, investors, partners, and founders.A significant part of Ken’s practice involves pre-litigation counseling for companies seeking to avoid litigation and/or to better prepare themselves for litigation that may arise. He has extensive experience in arbitration and mediation proceedings.

Kenneth A. Kuwayti

Partner

Christopher Gloria is a partner in the firm’s Patent Group. Mr. Gloria’s practice concentrates on domestic and international patent prosecution, IP due diligence, and IP litigation support including patent infringement and validity determinations.Mr. Gloria has drafted and prosecuted patents in numerous technology areas including medical devices, user interfaces, autonomous devices, image analysis, machine learning, and consumer products. Before attending law school, Mr. Gloria worked as an engineer in the semiconductor and aerospace industries.Mr. Gloria received his J.D. with highest honors from The George Washington University Law School where he was a member of The George Washington Law Review, a George Washington Scholar, and a Presidential Merit Scholarship recipient. He received his M.S. and B.S. in mechanical engineering from The University of Texas. He was previously a summer associate at the firm.Mr. Gloria is registered to practice before the Patent and Trademark Office and is licensed to practice law in the Commonwealth of Virginia.